Literature DB >> 35867306

Sleep Dysfunction in Movement Disorders: a Window to the Disease Biology.

Jordan Standlee1, Roneil Malkani2,3.   

Abstract

PURPOSE OF REVIEW: To comprehensively summarize the sleep pathologies associated with movement disorders, focusing on neurodegenerative diseases. RECENT
FINDINGS: Mounting evidence has further implicated both sleep and circadian disruption in the pathophysiology of many movement disorders. In particular, recent data illuminate the mechanisms by which poor sleep quality and circadian dysfunction can exacerbate neurodegeneration. In addition, anti-IgLON5 disease is a recently described autoimmune disease with various symptoms that can feature prominent sleep disruption and parasomnia. Many movement disorders are associated with sleep and circadian rhythm disruption. Motor symptoms can cause sleep fragmentation, resulting in insomnia and excessive daytime sleepiness. Many neurodegenerative movement disorders involve brainstem pathology in regions close to or affecting nuclei that regulate sleep and wake. Further, commonly used movement medications may exacerbate sleep concerns. Providers should screen for and address these sleep symptoms to improve function and quality of life for patients and caregivers.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  Choreiform disorder; Dystonia; Essential tremor; Movement disorders; Parkinsonism; Sleep dysfunction

Mesh:

Year:  2022        PMID: 35867306     DOI: 10.1007/s11910-022-01220-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   6.030


  105 in total

1.  Associated factors for REM sleep behavior disorder in Parkinson disease.

Authors:  Friederike Sixel-Döring; Ellen Trautmann; Brit Mollenhauer; Claudia Trenkwalder
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

Review 2.  Parkinson's disease and sleep.

Authors:  Diego Garcia-Borreguero; Oscar Larrosa; Mauricio Bravo
Journal:  Sleep Med Rev       Date:  2003-04       Impact factor: 11.609

Review 3.  REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions.

Authors:  Bradley F Boeve
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease.

Authors:  Juan Carlos Gómez-Esteban; Beatriz Tijero; Johanne Somme; Roberto Ciordia; Koldo Berganzo; Idoia Rouco; Jose Luis Bustos; Maria Antonia Valle; Elena Lezcano; Juan J Zarranz
Journal:  J Neurol       Date:  2010-10-19       Impact factor: 4.849

5.  REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.

Authors:  D O Claassen; K A Josephs; J E Ahlskog; M H Silber; M Tippmann-Peikert; B F Boeve
Journal:  Neurology       Date:  2010-07-28       Impact factor: 9.910

6.  Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease.

Authors:  C L Comella; T M Nardine; N J Diederich; G T Stebbins
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

Review 7.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

Review 8.  Non-motor symptoms in Parkinson's disease.

Authors:  W Poewe
Journal:  Eur J Neurol       Date:  2008-04       Impact factor: 6.089

9.  Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.

Authors:  Sebastian Paus; Hans Michael Brecht; Jürgen Köster; Gert Seeger; Thomas Klockgether; Ullrich Wüllner
Journal:  Mov Disord       Date:  2003-06       Impact factor: 10.338

10.  Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time.

Authors:  M D Gjerstad; B Boeve; T Wentzel-Larsen; D Aarsland; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.